THE EMS GROUP LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
Company Registration No. 13702723 (England and Wales)
THE EMS GROUP LIMITED
COMPANY INFORMATION
Directors
Mr K H Austin
Ms C I Echtle
Mr G A Goodwin
Mr C Hesbert
Mr I B Johnston
Ms C A Kendrew
Mr A E Stephens
Dr C A Grace
(Appointed 5 February 2024)
Mr R C Powell
(Appointed 17 April 2024)
Company number
13702723
Registered office
The Refinery
South Road
Ellesmere Port
CH65 4LE
Auditor
DSG Audit
Castle Chambers
43 Castle Street
Liverpool
L2 9TL
THE EMS GROUP LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3
Directors' responsibilities statement
4
Independent auditor's report
5 - 7
Group statement of comprehensive income
8
Group balance sheet
9 - 10
Company balance sheet
11
Group statement of changes in equity
12
Company statement of changes in equity
13
Group statement of cash flows
14
Notes to the financial statements
15 - 35
THE EMS GROUP LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -

The directors present the strategic report for the period ended 31 December 2024.

 

Principal activity

The principal activity of the company is that of a holding company.

 

The principal activity of the group is that of a leading provider of flexible medical and clinical research solutions.

Review of the business

The results of the group for the year, as set out on page 8, show turnover of £15.6m and a loss before taxation of £8.3m.

 

The group has made good progress in positioning itself in the Clinical Research sector, with the revenue reduction reflecting the run-off of legacy Covid-19 testing and roadshow contracts.

 

Net cash generated from operating activities for the year was £2.1m.

 

The group has largely completed its planned capital investment programme, resulting in lower capital expenditure of £2.8m (2023 - £6.4m) during the year.

 

Strategy

The group trades as “EMS Healthcare” with two divisions, as follows:

 

The group’s main objective is to increase long term value to its shareholders. This is achieved through a continued focus on the group’s vision and values.

 

Vision: A future where good health is within everyone’s reach

 

Values:

Principal risks and uncertainties

The management of the business and the nature of the group’s strategy are subject to a number of risks, as outlined by the directors below:

 

Credit risk

The group’s primary financial assets are bank balances and trade debtors. The group’s credit risk is primarily attributable to its trade debtors. The group structures its commercial agreements to minimise this risk and closely monitors its aged debts.

 

Interest rate risk

The interest rates on the group’s bank borrowings are linked to SONIA and are therefore subject to market fluctuations. The directors monitor the overall level of cash, borrowings and interest cost to limit any adverse effect on the financial performance of the group.

 

Economic risk

Rising inflation threatens to impact the group’s cost base. The business continues to review its procurement practices and its pricing strategy to new and existing customers.

 

Cyber risk

The group relies on its IT network for effective business communications and in support of providing operational services to its customers. The group continues to invest in business continuity technology to minimise the risk of cyber-crime.

THE EMS GROUP LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
Key performance indicators

The directors monitor the performance of the group using the following key performance indicators (KPI’s):

Future growth and developments

In March 2025, the group launched its first-ever Social Impact Report at The Houses of Parliament.

 

The launch coincided with the group’s 25th anniversary, demonstrates how the group has been breaking down barriers to healthcare and accelerating clinical research, ensuring that location, mobility, or circumstance never stand in the way of receiving quality care or participating in vital studies.

 

A copy of the report can be found at www.ems-healthcare.com

On behalf of the board

Dr C A Grace
Director
28 May 2025
THE EMS GROUP LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Results and dividends

The results for the year are set out on page 8.

No ordinary dividends were paid. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr K H Austin
Ms C I Echtle
Mr G A Goodwin
Mr C Hesbert
Mr I B Johnston
Ms C A Kendrew
Mr A E Stephens
Mr A Ul-Haq
(Resigned 17 April 2024)
Dr C A Grace
(Appointed 5 February 2024)
Mr R C Powell
(Appointed 17 April 2024)
Post reporting date events

There have been no post balance sheet events impacting the group or company.

Auditor

DSG resigned as auditor on 11 September 2024. DSG Audit were appointed on 11 September 2024 as auditor to the company and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

Strategic report

The group has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the group's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. The group has done so in respect of its principal activities, principal risks and future developments.

On behalf of the board
Dr C A Grace
Director
28 May 2025
THE EMS GROUP LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

THE EMS GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF THE EMS GROUP LIMITED
- 5 -
Opinion

We have audited the financial statements of The EMS Group Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

THE EMS GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF THE EMS GROUP LIMITED
- 6 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Irregularities

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

 

Discussions with and enquiries of management and those charged with governance were held with a view to identifying those laws and regulations that could be expected to have a material impact on the financial statements. During the engagement team briefing, the outcomes of these discussions and enquiries were shared with the team, as well as consideration as to where and how fraud may occur in the entity and group. The following laws and regulations were identified as being of significance to the entity and group:

 

Audit procedures undertaken in response to the potential risks relating to irregularities (which include fraud and non-compliance with laws and regulations) comprised of: inquiries of management and those charged with governance as to whether the entity and group complies with such laws and regulations; enquiries with the same concerning any actual or potential litigation or claims; inspection of relevant legal correspondence; review of board minutes; testing the appropriateness of journal entries and the performance of analytical review to identify unexpected movements in account balances which may be indicative of fraud.

THE EMS GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF THE EMS GROUP LIMITED
- 7 -

No instances of material non-compliance were identified. However, the likelihood of detecting irregularities, including fraud, is limited by the inherent difficulty in detecting irregularities, the effectiveness of the entity’s controls, and the nature, timing and extent of the audit procedures performed. Irregularities that result from fraud might be inherently more difficult to detect than irregularities that result from error. As explained above, there is an unavoidable risk that material misstatements may not be detected, even though the audit has been planned and performed in accordance with ISAs (UK).

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Jean Ellis BA FCA CTA (Senior Statutory Auditor)
For and on behalf of DSG Audit, Statutory Auditor
Chartered Accountants
Castle Chambers
43 Castle Street
Liverpool
L2 9TL
28 May 2025
THE EMS GROUP LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
2024
2023
Notes
£
£
Turnover
3
15,552,383
17,705,453
Cost of sales
(5,220,498)
(5,601,808)
Gross profit
10,331,885
12,103,645
Administrative expenses
(15,718,118)
(15,073,816)
Exceptional item
4
(41,071)
(496,943)
Operating loss
5
(5,427,304)
(3,467,114)
Interest receivable and similar income
8
13,410
15,659
Interest payable and similar expenses
9
(2,911,260)
(2,603,647)
Loss before taxation
(8,325,154)
(6,055,102)
Tax on loss
10
(166,892)
172,549
Loss for the financial year
(8,492,046)
(5,882,553)
Loss for the financial year is all attributable to the owners of the parent company.
Total comprehensive income for the year is all attributable to the owners of the parent company.

The notes on pages 15 to 35 form part of these financial statements.

THE EMS GROUP LIMITED
GROUP BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 9 -
2024
2023
Notes
£
£
£
£
Fixed assets
Goodwill
11
26,256,277
29,970,827
Other intangible assets
11
320,517
1,293,275
Total intangible assets
26,576,794
31,264,102
Tangible assets
12
24,480,456
25,339,383
51,057,250
56,603,485
Current assets
Stocks
15
13,446
33,673
Debtors falling due after more than one year
16
1,726,203
240,341
Debtors falling due within one year
16
2,251,637
3,865,010
Cash at bank and in hand
2,113,429
1,284,132
6,104,715
5,423,156
Creditors: amounts falling due within one year
17
(4,366,127)
(5,130,236)
Net current assets
1,738,588
292,920
Total assets less current liabilities
52,795,838
56,896,405
Creditors: amounts falling due after more than one year
18
(30,458,914)
(26,964,691)
Provisions for liabilities
Provisions
20
1,032,723
1,032,723
Deferred tax liability
21
4,227,400
3,330,144
(5,260,123)
(4,362,867)
Net assets
17,076,801
25,568,847
Capital and reserves
Called up share capital
24
217,994
217,994
Share premium account
38,484,425
38,484,425
Profit and loss reserves
(21,625,618)
(13,133,572)
Total equity
17,076,801
25,568,847
THE EMS GROUP LIMITED
GROUP BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2024
31 December 2024
- 10 -

These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.

The financial statements were approved by the board of directors and authorised for issue on 28 May 2025 and are signed on its behalf by:
28 May 2025
Dr C A Grace
Director
Company registration number 13702723 (England and Wales)
THE EMS GROUP LIMITED
COMPANY BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 11 -
2024
2023
Notes
£
£
£
£
Fixed assets
Investments
13
52,000,000
52,000,000
Current assets
Debtors falling due after more than one year
16
6,696,189
6,061,473
Debtors falling due within one year
16
118,202
141,663
Cash at bank and in hand
267,873
203,587
7,082,264
6,406,723
Creditors: amounts falling due within one year
17
(691,817)
(655,875)
Net current assets
6,390,447
5,750,848
Total assets less current liabilities
58,390,447
57,750,848
Creditors: amounts falling due after more than one year
18
(26,458,914)
(23,964,691)
Net assets
31,931,533
33,786,157
Capital and reserves
Called up share capital
24
217,994
217,994
Share premium account
38,484,425
38,484,425
Profit and loss reserves
(6,770,886)
(4,916,262)
Total equity
31,931,533
33,786,157

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s loss for the year was £1,854,624 (2023 - £1,777,231 loss).

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 28 May 2025 and are signed on its behalf by:
28 May 2025
Dr C A Grace
Director
Company registration number 13702723 (England and Wales)
THE EMS GROUP LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 12 -
Share capital
Share premium account
Profit and loss reserves
Total
£
£
£
£
Balance at 1 January 2023
217,994
38,484,425
(7,251,019)
31,451,400
Year ended 31 December 2023:
Loss and total comprehensive income
-
-
(5,882,553)
(5,882,553)
Balance at 31 December 2023
217,994
38,484,425
(13,133,572)
25,568,847
Year ended 31 December 2024:
Loss and total comprehensive income
-
-
(8,492,046)
(8,492,046)
Balance at 31 December 2024
217,994
38,484,425
(21,625,618)
17,076,801
THE EMS GROUP LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 13 -
Share capital
Share premium account
Profit and loss reserves
Total
£
£
£
£
Balance at 1 January 2023
217,994
38,484,425
(3,139,031)
35,563,388
Year ended 31 December 2023:
Loss and total comprehensive income for the year
-
-
(1,777,231)
(1,777,231)
Balance at 31 December 2023
217,994
38,484,425
(4,916,262)
33,786,157
Year ended 31 December 2024:
Loss and total comprehensive income for the year
-
-
(1,854,624)
(1,854,624)
Balance at 31 December 2024
217,994
38,484,425
(6,770,886)
31,931,533
THE EMS GROUP LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 14 -
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
28
4,998,071
6,911,131
Interest paid
(2,911,260)
(2,603,647)
Net cash inflow from operating activities
2,086,811
4,307,484
Investing activities
Purchase of intangible assets
(84,273)
(36,372)
Purchase of tangible fixed assets
(2,836,391)
(6,439,747)
Proceeds from disposal of tangible fixed assets
649,740
669,498
Interest received
13,410
15,659
Net cash used in investing activities
(2,257,514)
(5,790,962)
Financing activities
Proceeds from new bank loans
1,000,000
1,000,000
Payment of finance leases obligations
-
(287,240)
Net cash generated from financing activities
1,000,000
712,760
Net increase/(decrease) in cash and cash equivalents
829,297
(770,718)
Cash and cash equivalents at beginning of year
1,284,132
2,054,850
Cash and cash equivalents at end of year
2,113,429
1,284,132
THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 15 -
1
Accounting policies
Company information

The EMS Group Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is The Refinery, South Road, Ellesmere Port, CH65 4LE.

 

The group consists of The EMS Group Limited and all of its subsidiaries.

 

The principal activities of the group and company are disclosed in the Strategic Report.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

 

1.2
Business combinations

In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.

 

Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 16 -
1.3
Basis of consolidation

The consolidated group financial statements consist of the financial statements of the parent company The EMS Group Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.

 

All financial statements are made up to 31 December 2024. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.

1.4
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

 

A private equity investment by Lloyds Development Capital (LDC) on 25th January 2022 and the subsequent refinancing with Lloyds Banking Group has provided the group with cash and the ability to borrow to fund its growth plan.

 

This is further supported by the group having several long-term contracts that will continue to generate revenue and there is visibility in the sales pipeline of new contracts into the future. The group will continue to maintain a sound financial plan and continue to monitor key financial indicators, to identify and address any potential risks. A cross company guarantee exists across group companies.

 

Based on the above, the directors consider it appropriate to prepare these financial statements on a going concern basis.

1.5
Turnover

Turnover represents the amount derived from ordinary activities, stated after trade discounts, VAT and any other taxes.

 

Turnover from contracts for the supply and management of mobile medical and research facilities is recognised by reference to the stage of contract completion. The stage of completion is calculated by comparing activities undertaken, mainly in relation to number of days hire, staff time incurred and materials consumed, against the agreed contract terms. Where activities are outside of the scope of a contract, turnover is recognised only to the extent that the expenses incurred are recoverable.

Other income

Interest income is accrued on a time-apportioned basis, by reference to the principal outstanding at the effective interest rate.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 17 -
1.6
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of a business over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.7
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software
33% straight line
Customer contracts
Over the life of the contract
Loan arrangement fees
Over the course of the loan
1.8
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
Over the term of the lease
Plant and equipment
25% reducing balance
Fixtures and fittings
25% and 33% reducing balance and 33% straight line
Motor vehicles
25% reducing balance
Equipment
Between 10% and 33% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

1.9
Fixed asset investments

Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.

 

In the parent company financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 18 -

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.10
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

 

The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.11
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.12
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 19 -
1.13
Financial instruments

The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 20 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.14
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.15
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 21 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.16
Provisions

Provisions are recognised when the group has a legal or constructive present obligation as a result of a past event, it is probable that the group will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

1.17
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.18
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.19
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 22 -
1.20

Key-employee share option scheme

Certain employees participate in share option schemes, which provide additional remuneration for those employees who are key to the operations of the group. Options granted with an exercise price determined by the Board, are exercisable on an Exit Event and expire ten years after the date of grant. Employees are not entitled to dividends until the share options are exercised.

 

At 31 December 2024, 45,785 Enterprise Management Incentive (EMI) options had been granted with an exercise price of £1.2403.

 

During the year, a new Company Share Option Plan (CSOP) scheme was established and 12,944 CSOP share options were granted with an exercise price of £3.00.

2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Revenue recognition

Managerial judgement is applied to determine if revenue and costs should be recognised in the current period. This is based on the degree of project completion and foreseeable profits.

Lease recognition

In categorising leases as finance or operating leases, management makes judgement as to whether the significant risks and rewards of ownership have transferred to the group.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
2
Judgements and key sources of estimation uncertainty
(Continued)
- 23 -
Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Asset recognition

Property, plant and equipment is a significant proportion of the asset base of the Group. Therefore the estimates and assumptions made to determine their carrying value and related depreciation are critical to the Group's financial position and performance.

 

When an asset is purchased it is categorised into an asset class, the depreciation policy of each class estimates the useful economic life of all assets within the class.

 

The depreciation policy of each asset class is determined by management and reviewed regularly for appropriateness. The depreciation policy adopted is based on historical experience as well as considering future events which may impact the useful economic life of assets within each class, such as changes in market demands.

 

In addition FRS 102 requires an entity to asses at each reporting date whether there is any indication that assets within a class may be impaired, i.e. recoverable amount of the asset is less than the carrying amount. If such indication exists, management are required to estimate the recoverable amount of the individual asset concerned.

3
Turnover and other revenue
2024
2023
£
£
Turnover analysed by class of business
Provision of goods and services
15,552,383
17,705,453
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
14,416,735
16,130,262
Europe
1,135,648
1,575,191
15,552,383
17,705,453
2024
2023
£
£
Other revenue
Interest income
13,410
15,659
THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 24 -
4
Exceptional item
2024
2023
£
£
Expenditure
Restructuring and reorganisation
78,296
496,943
M&A related charges
(37,225)
-
41,071
496,943

Restructuring and reorganisation charges include staff redundancy costs, costs of refinancing and other associated costs.

 

M&A related charged include legal and consulting costs in respect of the acquisition of subsidiaries.

5
Operating loss
2024
2023
£
£
Operating loss for the year is stated after charging/(crediting):
Exchange losses
4,157
11,388
Auditors' remuneration
17,425
16,550
Depreciation of owned tangible fixed assets
2,975,235
2,598,382
Loss/(profit) on disposal of tangible fixed assets
70,343
(146,450)
Amortisation of intangible assets
4,771,581
5,525,414
Operating lease charges
122,720
157,184
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2024
2023
2024
2023
Number
Number
Number
Number
Directors
7
6
7
6
Direct labour
60
67
-
-
Administration
70
83
-
-
Total
137
156
7
6
THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
6
Employees
(Continued)
- 25 -

Their aggregate remuneration comprised:

Group
Company
2024
2023
2024
2023
£
£
£
£
Wages and salaries
4,355,756
3,823,776
887,965
627,429
Social security costs
610,761
631,846
77,158
78,632
Pension costs
234,482
191,488
101,334
60,000
5,200,999
4,647,110
1,066,457
766,061
7
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
842,632
735,976
Company pension contributions to defined contribution schemes
101,334
60,000
943,966
795,976

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 5 (2023 - 4).

Remuneration disclosed above includes the following amounts paid to the highest paid director:
2024
2023
£
£
Remuneration for qualifying services
253,798
187,325
Company pension contributions to defined contribution schemes
13,750
40,000
8
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest on bank deposits
13,410
15,659
9
Interest payable and similar expenses
2024
2023
£
£
Interest on bank overdrafts and loans
417,037
348,839
Interest on finance leases and hire purchase contracts
-
1,512
Other interest
2,494,223
2,253,296
Total finance costs
2,911,260
2,603,647
THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 26 -
10
Taxation
2024
2023
£
£
Current tax
Adjustments in respect of prior periods
-
0
90,231
Deferred tax
Origination and reversal of timing differences
166,892
(262,780)
Total tax charge/(credit)
166,892
(172,549)

The actual charge/(credit) for the year can be reconciled to the expected credit for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Loss before taxation
(8,325,154)
(6,055,102)
Expected tax credit based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
(2,081,289)
(1,424,160)
Tax effect of expenses that are not deductible in determining taxable profit
201,629
237,119
Adjustments in respect of prior years
-
0
90,231
Effect of change in corporation tax rate
-
24,628
Permanent capital allowances in excess of depreciation
1,178,105
1,212,172
Other non-reversing timing differences
-
0
(541,983)
Movement in deferred tax not recognised
868,447
229,444
Taxation charge/(credit)
166,892
(172,549)

At the year end the group had tax losses available for carry forward to future financial years amounting to £6,041,458. Based on these losses a deferred tax asset has been recognised.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 27 -
11
Intangible fixed assets
Group
Goodwill
Software
Customer contracts
Loan arrangement fees
Total
£
£
£
£
£
Cost
At 1 January 2024
37,145,507
86,745
7,034,522
375,000
44,641,774
Additions
-
0
84,273
-
0
-
0
84,273
At 31 December 2024
37,145,507
171,018
7,034,522
375,000
44,726,047
Amortisation and impairment
At 1 January 2024
7,174,680
34,877
6,080,615
87,500
13,377,672
Amortisation charged for the year
3,714,550
28,124
953,907
75,000
4,771,581
At 31 December 2024
10,889,230
63,001
7,034,522
162,500
18,149,253
Carrying amount
At 31 December 2024
26,256,277
108,017
-
0
212,500
26,576,794
At 31 December 2023
29,970,827
51,868
953,907
287,500
31,264,102
The company had no intangible fixed assets at 31 December 2024 or 31 December 2023.
THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 28 -
12
Tangible fixed assets
Group
Leasehold improvements
Plant and equipment
Fixtures and fittings
Motor vehicles
Equipment
Total
£
£
£
£
£
£
Cost
At 1 January 2024
1,146,611
249,352
496,207
462,736
25,900,817
28,255,723
Additions
67,576
17,971
71,392
2,453
2,676,999
2,836,391
Disposals
-
0
-
0
-
0
-
0
(881,460)
(881,460)
At 31 December 2024
1,214,187
267,323
567,599
465,189
27,696,356
30,210,654
Depreciation and impairment
At 1 January 2024
312,319
157,848
332,434
217,273
1,896,466
2,916,340
Depreciation charged in the year
101,505
26,531
79,942
57,702
2,709,555
2,975,235
Eliminated in respect of disposals
-
0
-
0
-
0
-
0
(161,377)
(161,377)
At 31 December 2024
413,824
184,379
412,376
274,975
4,444,644
5,730,198
Carrying amount
At 31 December 2024
800,363
82,944
155,223
190,214
23,251,712
24,480,456
At 31 December 2023
834,292
91,504
163,773
245,463
24,004,351
25,339,383
The company had no tangible fixed assets at 31 December 2024 or 31 December 2023.
13
Fixed asset investments
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Investments in subsidiaries
14
-
0
-
0
52,000,000
52,000,000
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 January 2024 and 31 December 2024
52,000,000
Carrying amount
At 31 December 2024
52,000,000
At 31 December 2023
52,000,000
THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 29 -
14
Subsidiaries

Details of the company's subsidiaries at 31 December 2024 are as follows:

Name of undertaking
Address
Class of
% Held
shares held
Direct
Indirect
EMS Group Solutions Limited
1
Ordinary
100.00
-
EMS EMEA Limited
1
Ordinary
0
100.00
EMS Production Limited
1
Ordinary
0
100.00
EMS Healthcare Limited
1
Ordinary
0
100.00
Event Marketing Solutions Limited
1
Ordinary
0
100.00

Dormant companies have been excluded from the consolidated accounts as their inclusion would not have a material impact.

 

Registered office addresses:

1
The Refinery, South Road, Ellesmere Port, United Kingdom, CH65 4LE

The subsidiary companies Event Marketing Solutions Limited, EMS Production Limited, EMS EMEA Limited and EMS Healthcare Limited have taken exemption under Section 479A of the Companies Act 2006 (the Act) from the requirement in the Act for their individual accounts to be audited. The guarantee given by the company under Section 479A is disclosed.

15
Stocks
Group
Company
2024
2023
2024
2023
£
£
£
£
Work in progress
1,501
7,782
-
-
Finished goods and goods for resale
11,945
25,891
-
0
-
0
13,446
33,673
-
-
THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 30 -
16
Debtors
Group
Company
2024
2023
2024
2023
Amounts falling due within one year:
£
£
£
£
Trade debtors
1,345,455
2,172,064
-
0
-
0
Amounts owed by group undertakings
-
-
117,372
140,972
Other debtors
101,234
84,908
-
0
-
0
Prepayments and accrued income
804,948
828,038
830
691
2,251,637
3,085,010
118,202
141,663
Deferred tax asset (note 21)
-
0
780,000
-
0
-
0
2,251,637
3,865,010
118,202
141,663
Amounts falling due after more than one year:
Amounts owed by group undertakings
-
-
6,696,189
6,061,473
Amount owed by related parties
215,839
240,341
-
0
-
0
215,839
240,341
6,696,189
6,061,473
Deferred tax asset (note 21)
1,510,364
-
0
-
0
-
0
1,726,203
240,341
6,696,189
6,061,473
Total debtors
3,977,840
4,105,351
6,814,391
6,203,136

In the company, amounts owed by group undertakings relates to loan notes given to EMS Group Solutions Limited amounting to £5,000,000. Interest is charged on these loan notes at 10% per annum.

17
Creditors: amounts falling due within one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Trade creditors
1,061,504
2,052,525
11,896
65,340
Amounts owed to group undertakings
-
0
-
0
574,930
447,351
Corporation tax payable
-
0
90,231
-
0
-
0
Other taxation and social security
432,759
457,350
80,491
83,060
Deferred income
22
2,710,073
2,199,826
-
0
-
0
Other creditors
25,735
147,954
24,500
23,000
Accruals
136,056
182,350
-
0
37,124
4,366,127
5,130,236
691,817
655,875

Amounts owed to group undertakings are interest free, have no fixed date of repayment and are repayable upon demand.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 31 -
18
Creditors: amounts falling due after more than one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Revolving Credit Facility
19
4,000,000
3,000,000
-
0
-
0
Other borrowings
19
26,458,914
23,964,691
26,458,914
23,964,691
30,458,914
26,964,691
26,458,914
23,964,691
19
Loans
Group
Company
2024
2023
2024
2023
£
£
£
£
Other borrowings
4,000,000
3,000,000
-
0
-
0
Other loans
26,458,914
23,964,691
26,458,914
23,964,691
30,458,914
26,964,691
26,458,914
23,964,691
Payable after one year
30,458,914
26,964,691
26,458,914
23,964,691

Other borrowings relate to a Revolving Credit Facility ("RCF") of £4,000,000 (2023: £3,000,000). This loan balance is split into 3 tranches. The first tranche is due for repayment in February 2025. Interest is charged on this at a rate of 2.90% over SONIA. The second tranche is due for repayment in February 2025. Interest is charged on this at a rate of 2.90% over SONIA. The third tranche is due for repayment in March 2025. Interest is charged on this at a rate of 2.90% over SONIA. Security for the facility takes the form of a fixed and floating charge over all of the property or undertaking of the company. Following the year end, the RCF has been extended and all three tranches are now due for repayment in November 2025.

 

The loan note instruments were created on 25th January 2022.

 

The principal amounts of the loan notes (£19,796,880) are repayable in full upon the earlier of: the date of sale or listing of the company, 6 months following any loan facility or credit agreement provided by one or more third party or 25th May 2028.

 

Interest is accrued until the principal amount is paid off. Interest is compounded quarterly and added to the principal amount and is repayable in full in line with the principal amount. Interest on the Loan notes is calculated daily at a rate of 10% per annum on the principal amount outstanding.

20
Provisions for liabilities
Group
Company
2024
2023
2024
2023
£
£
£
£
Dilapidations provision
1,032,723
1,032,723
-
-
THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
20
Provisions for liabilities
(Continued)
- 32 -
Movements on provisions:
Dilapidations provision
Group
£
At 1 January 2024 and 31 December 2024
1,032,723

The year end provision relates to dilapidations on leased premises which is payable on the earlier of the surrender of the lease or when the work has been completed.

21
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:

Liabilities
Liabilities
Assets
Assets
2024
2023
2024
2023
Group
£
£
£
£
Accelerated capital allowances
4,227,400
3,330,144
-
-
Tax losses
-
-
1,510,364
780,000
4,227,400
3,330,144
1,510,364
780,000
The company has no deferred tax assets or liabilities.
Group
Company
2024
2024
Movements in the year:
£
£
Liability at 1 January 2024
2,550,144
-
Charge to profit or loss
166,892
-
Liability at 31 December 2024
2,717,036
-

The deferred tax liability set out above is expected to reverse within 5 years and relates to accelerated capital allowances that are expected to mature within the same period.

22
Deferred income
Group
Company
2024
2023
2024
2023
£
£
£
£
Other deferred income
2,710,073
2,199,826
-
-
THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 33 -
23
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
234,482
191,488

A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.

24
Share capital
Group and company
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
A1 Ordinary shares of 30p each
200,000
200,000
60,001
60,000
A2 Ordinary shares of 30p each
1,942
1,942
583
583
B Ordinary shares of 40p each
388,997
388,997
155,598
155,599
C Ordinary shares of 40p each
4,531
4,531
1,812
1,812
595,470
595,470
217,994
217,994
25
Operating lease commitments
Lessee

At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Group
Company
2024
2023
2024
2023
£
£
£
£
Within one year
282,917
300,250
-
-
Between two and five years
1,097,000
1,105,666
-
-
In over five years
758,562
1,032,812
-
-
2,138,479
2,438,728
-
-
THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 34 -
26
Related party transactions

On 25th January 2022 the group issued two A1 Loan notes to companies with significant influence over the group totalling £9,711,265 and £71,885. The Loan notes are repayable 25th May 2028 and accrue daily interest at 10% per annum. The amount of interest expensed in the year ended 31st December 2024 was £1,232,586, the full amount was accrued as at 31st December 2024 and is disclosed within other borrowings falling due after one year.

 

On 25th January 2022 the group issued two A2 Loan notes to companies with significant influence over the group totalling £9,711,265 and £71,885. The Loan notes are repayable 25th May 2028 and accrue daily interest at 10% per annum. The amount of interest expensed in the year ended 31st December 2024 was £1,232,586, the full amount was accrued as at 31st December 2024 and is disclosed within other borrowings falling due after one year.

 

On 25th January 2022 the group issued a B1 Loan note to a director of the group totalling £186,134. The Loan note is repayable 25th May 2028 and accrues daily interest at 10% per annum. The amount of interest expensed in the year ended 31st December 2024 was £23,451, the full amount was accrued as at 31st December 2024 and is disclosed within other borrowings falling due after one year.

 

On 25th January 2022 the group issued a B2 Loan note to a director of the group totalling £44,447. The Loan note is repayable 25th May 2028 and accrues daily interest at 10% per annum. The amount of interest expensed in the year ended 31st December 2024 was £5,600, the full amount was accrued as at 31st December 2024 and is disclosed within other borrowings falling due after one year.

 

During the year, rent was charged to the company amounting to £80,140 (2023: £80,140) by the EMS Directors SSAS. Rent was also charged to the company amounting to £141,610 (2023: £141,610) by Shellway Investments Limited. At the year end date, a balance was due from Shellway Investments of £240,076 (2023: £262,158). Both EMS Directors SSAS and Shellway Investments were controlled by a director that also had significant influence over the group.

 

The company has taken advantage of the reduced disclosure exemption available under Financial Reporting Standard 102 relating to the disclosure of related party transactions between wholly owned group companies.

 

No other transactions with related parties were undertaken such as are required to be disclosed Financial Reporting Standard 102.

27
Controlling party

In the opinion of the directors, The EMS Group Limited has no ultimate controlling party.

THE EMS GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 35 -
28
Cash generated from group operations
2024
2023
£
£
Loss after taxation
(8,492,046)
(5,882,553)
Adjustments for:
Taxation charged/(credited)
166,892
(172,549)
Finance costs
2,911,260
2,603,647
Investment income
(13,410)
(15,659)
Loss/(gain) on disposal of tangible fixed assets
70,343
(146,450)
Amortisation and impairment of intangible assets
4,771,581
5,525,414
Depreciation and impairment of tangible fixed assets
2,975,235
2,598,382
Movements in working capital:
Decrease in stocks
20,227
139,803
Decrease/(increase) in debtors
857,875
(633,667)
Increase in creditors
1,219,867
2,822,810
Increase in deferred income
510,247
71,953
Cash generated from operations
4,998,071
6,911,131
29
Analysis of changes in net debt - group
1 January 2024
Cash flows
31 December 2024
£
£
£
Cash at bank and in hand
1,284,132
829,297
2,113,429
Borrowings excluding overdrafts
(26,964,691)
(3,494,223)
(30,458,914)
(25,680,559)
(2,664,926)
(28,345,485)
2024-12-312024-01-01falsefalseCCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr K H AustinMs C I EchtleMr G A GoodwinMr C HesbertMr I B JohnstonMs C A KendrewMr A E StephensMr A Ul-HaqDr C A GraceMr R C Powellfalse137027232024-01-012024-12-3113702723bus:Director12024-01-012024-12-3113702723bus:Director22024-01-012024-12-3113702723bus:Director32024-01-012024-12-3113702723bus:Director42024-01-012024-12-3113702723bus:Director52024-01-012024-12-3113702723bus:Director62024-01-012024-12-3113702723bus:Director72024-01-012024-12-3113702723bus:Director92024-01-012024-12-3113702723bus:Director102024-01-012024-12-3113702723bus:Director82024-01-012024-12-3113702723bus:RegisteredOffice2024-01-012024-12-31137027232024-12-3113702723bus:Consolidated2024-12-3113702723bus:Consolidated2024-01-012024-12-3113702723bus:Consolidated2023-01-012023-12-3113702723bus:Consolidated12024-01-012024-12-3113702723bus:Consolidated12023-01-012023-12-31137027232023-01-012023-12-3113702723core:Goodwillbus:Consolidated2024-12-3113702723core:Goodwillbus:Consolidated2023-12-3113702723core:OtherResidualIntangibleAssetsbus:Consolidated2024-12-3113702723core:OtherResidualIntangibleAssetsbus:Consolidated2023-12-3113702723bus:Consolidated2023-12-3113702723core:ComputerSoftwarebus:Consolidated2024-12-3113702723core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2024-12-3113702723core:Non-standardIntangibleAssetClass2ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2024-12-3113702723core:ComputerSoftwarebus:Consolidated2023-12-3113702723core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2023-12-3113702723core:Non-standardIntangibleAssetClass2ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2023-12-3113702723core:LeaseholdImprovementsbus:Consolidated2024-12-3113702723core:PlantMachinerybus:Consolidated2024-12-3113702723core:FurnitureFittingsbus:Consolidated2024-12-3113702723core:MotorVehiclesbus:Consolidated2024-12-3113702723core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipmentbus:Consolidated2024-12-3113702723core:LeaseholdImprovementsbus:Consolidated2023-12-3113702723core:PlantMachinerybus:Consolidated2023-12-3113702723core:FurnitureFittingsbus:Consolidated2023-12-3113702723core:MotorVehiclesbus:Consolidated2023-12-3113702723core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipmentbus:Consolidated2023-12-31137027232023-12-3113702723core:ShareCapitalbus:Consolidated2024-12-3113702723core:ShareCapitalbus:Consolidated2023-12-3113702723core:SharePremiumbus:Consolidated2024-12-3113702723core:SharePremiumbus:Consolidated2023-12-3113702723core:RetainedEarningsAccumulatedLossesbus:Consolidated2023-12-3113702723core:ShareCapital2024-12-3113702723core:ShareCapital2023-12-3113702723core:SharePremium2024-12-3113702723core:SharePremium2023-12-3113702723core:RetainedEarningsAccumulatedLosses2024-12-3113702723core:RetainedEarningsAccumulatedLosses2023-12-3113702723core:ShareCapitalbus:Consolidated2022-12-3113702723core:SharePremiumbus:Consolidated2022-12-31137027232022-12-3113702723core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-12-3113702723core:ShareCapital2022-12-3113702723core:SharePremium2022-12-3113702723core:RetainedEarningsAccumulatedLosses2022-12-3113702723core:Non-currentFinancialInstruments2024-12-3113702723core:Non-currentFinancialInstruments2023-12-3113702723bus:Consolidated2022-12-3113702723core:Goodwill2024-01-012024-12-3113702723core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3113702723core:ComputerSoftware2024-01-012024-12-3113702723core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-01-012024-12-3113702723core:Non-standardIntangibleAssetClass2ComponentIntangibleAssetsOtherThanGoodwill2024-01-012024-12-3113702723core:LeaseholdImprovements2024-01-012024-12-3113702723core:PlantMachinery2024-01-012024-12-3113702723core:FurnitureFittings2024-01-012024-12-3113702723core:MotorVehicles2024-01-012024-12-3113702723core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-01-012024-12-3113702723core:UKTaxbus:Consolidated2024-01-012024-12-3113702723core:UKTaxbus:Consolidated2023-01-012023-12-3113702723core:Goodwillbus:Consolidated2023-12-3113702723core:ComputerSoftwarebus:Consolidated2023-12-3113702723core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2023-12-3113702723core:Non-standardIntangibleAssetClass2ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2023-12-3113702723bus:Consolidated2023-12-3113702723core:Goodwillcore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3113702723core:ComputerSoftwarecore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3113702723core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillcore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3113702723core:Non-standardIntangibleAssetClass2ComponentIntangibleAssetsOtherThanGoodwillcore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3113702723core:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3113702723core:Goodwillbus:Consolidated2024-01-012024-12-3113702723core:ComputerSoftwarebus:Consolidated2024-01-012024-12-3113702723core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2024-01-012024-12-3113702723core:Non-standardIntangibleAssetClass2ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2024-01-012024-12-3113702723core:LeaseholdImprovementsbus:Consolidated2023-12-3113702723core:PlantMachinerybus:Consolidated2023-12-3113702723core:FurnitureFittingsbus:Consolidated2023-12-3113702723core:MotorVehiclesbus:Consolidated2023-12-3113702723core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipmentbus:Consolidated2023-12-3113702723core:LeaseholdImprovementsbus:Consolidated2024-01-012024-12-3113702723core:PlantMachinerybus:Consolidated2024-01-012024-12-3113702723core:FurnitureFittingsbus:Consolidated2024-01-012024-12-3113702723core:MotorVehiclesbus:Consolidated2024-01-012024-12-3113702723core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipmentbus:Consolidated2024-01-012024-12-3113702723core:Subsidiary12024-01-012024-12-3113702723core:Subsidiary22024-01-012024-12-3113702723core:Subsidiary32024-01-012024-12-3113702723core:Subsidiary42024-01-012024-12-3113702723core:Subsidiary52024-01-012024-12-3113702723core:Subsidiary112024-01-012024-12-3113702723core:Subsidiary222024-01-012024-12-3113702723core:Subsidiary332024-01-012024-12-3113702723core:Subsidiary442024-01-012024-12-3113702723core:Subsidiary552024-01-012024-12-3113702723core:CurrentFinancialInstruments2024-12-3113702723core:CurrentFinancialInstruments2023-12-3113702723core:CurrentFinancialInstrumentsbus:Consolidated2024-12-3113702723core:CurrentFinancialInstrumentsbus:Consolidated2023-12-3113702723core:Non-currentFinancialInstrumentsbus:Consolidated2024-12-3113702723core:Non-currentFinancialInstrumentsbus:Consolidated2023-12-3113702723core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-12-3113702723core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2023-12-3113702723core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3113702723core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3113702723core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-12-3113702723core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2023-12-3113702723core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3113702723core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3113702723bus:PrivateLimitedCompanyLtd2024-01-012024-12-3113702723bus:FRS1022024-01-012024-12-3113702723bus:Audited2024-01-012024-12-3113702723bus:ConsolidatedGroupCompanyAccounts2024-01-012024-12-3113702723bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP